首页> 外文期刊>Journal of orthopaedic trauma >Effectiveness of Vitamin D Therapy in Orthopaedic Trauma Patients
【24h】

Effectiveness of Vitamin D Therapy in Orthopaedic Trauma Patients

机译:维生素D治疗创伤骨科患者的有效性

获取原文
获取原文并翻译 | 示例
       

摘要

Objective:The purpose of this study was to determine the effectiveness of our vitamin D treatment protocol in managing low serum vitamin D levels in orthopaedic trauma patients.Methods:A retrospective review was conducted of all orthopaedic trauma patients at a university level I trauma center over 20 months. Patients were included if they had an initial and repeat 25-hydroxy (OH) vitamin D serum level available. Vitamin D deficiency was defined as serum 25-hydroxy vitamin D level with less than 20 ng/mL. Vitamin D insufficiency was defined as serum 25-hydroxy vitamin D level between 20 and 32 ng/mL. The standard regimen for all patients was over-the-counter vitamin D-3 1000 IU and 1500 mg of calcium daily. Patients with vitamin D deficiency or insufficiency also received 50,000 IU of ergocalciferol (D2) weekly until their 25-hydroxyvitamin D level normalized or their fracture healed. No compliance monitoring was performed except for questioning at each clinic visit.Results:A total of 201 patients met the inclusion criteria. Thirty-two patients had a normal initial 25-hydroxyvitamin D level, and 84% maintained their normal level, whereas 16% became insufficient or deficient. There were 88 patients insufficient initially and 54.5% improved to normal and 8% became deficient. In the vitamin D deficiency group (81), 26% remained deficient and 74% improved to insufficient. The average increase in serum 25-OH vitamin D with treatment (in nanograms per milliliter) was statistically significant for both the insufficient and deficient groups.Conclusions:Vitamin D therapy improved the majority of the patients' vitamin D-25-OH level but did not normalize most. Patients with initial deficiency had the largest improvement. This study indicates that vigilance is required to adequately treat a low serum vitamin D-25-OH level.Level of Evidence:Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
机译:目的:本研究的目的是确定我们的维生素D治疗方案在管理骨伤患者中低血清维生素D水平方面的有效性。方法:回顾性地回顾了大学一级I创伤中心的所有骨伤患者20个月如果患者具有初始和重复的25-羟基(OH)维生素D血清水平,则将其包括在内。维生素D缺乏症定义为血清25-羟基维生素D水平低于20 ng / mL。维生素D功能不全定义为血清25-羟基维生素D水平在20到32 ng / mL之间。所有患者的标准治疗方案均为非处方维生素D-3 1000 IU和每日1500 mg钙。维生素D缺乏或不足的患者每周还接受50,000 IU麦角钙化固醇(D2),直到其25-羟基维生素D水平恢复正常或骨折愈合为止。结果:总共201例患者符合入组标准。 32例患者的初始25-羟基维生素D水平正常,而84%的患者维持其正常水平,而16%的患者不足或不足。最初有88例病人不足,有54.5%的病人恢复正常,有8%的病人不足。在维生素D缺乏症组中(81),仍有26%的人缺乏,而74%的人改善为不足。不足和不足组的患者血清25-OH维生素D的平均增加(以纳克/毫升为单位)具有统计学意义。结论:维生素D治疗改善了大多数患者的维生素D-25-OH水平,但确实最不规范。最初缺乏的患者改善最大。这项研究表明,要充分治疗低血清维生素D-25-OH水平需要警惕。证据级别:治疗级别IV。有关证据水平的完整说明,请参见《作者说明》。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号